This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Pandemic-stage propagation dynamics in South Africa suggest pre-existing cross-reactive protection against severe Covid-19 (preprint)
researchsquare; 2021.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-394828.v1
ABSTRACT
Early in the Covid-19 outbreak, it was speculated that pre-existing cross-reactive immunity from prior BCG vaccination or exposure to common cold human coronaviruses might confer some protection against Covid-19. Following a year of circulation of SARS-CoV-2 through the world, epidemiological dynamics allow a test of this hypothesis. A dynamic epidemiological model was fitted to the Covid-19 attributed ‘excess deaths’ in South Africa, a country with a long-standing BCG vaccination program and where social-economic circumstances potentially result in frequent exposure to common cold coronaviruses. We show that Covid-19 propagation dynamics in South Africa are consistent with an initially fully susceptible population (no prior cross-immunity protecting against infection), but this requires assuming values of the infection fatality rate (IFR) below or at the lower plausible range (0.31 to 0.53) of internationally reported values. This suggests that some form of pre-existing protection against severe Covid-19 may exist in South Africa. The observed disease propagation dynamics can be explained by both long-lasting immunity and various scenarios of reinfection in the presence of the more transmissible B.1.351 variant, which is also relatively resistant to antibodies induced by infections of prototype SARS-CoV-2. All scenarios of reinfection also require assuming a low IFR in order to replicate the observed attributes of the outbreak.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
COVID-19
Language:
English
Year:
2021
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS